AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURGICAL INNOVATIONS GROUP PLC

Director's Dealing Oct 16, 2018

7938_dirs_2018-10-16_bac2570b-5fb8-4d30-a2b8-1867cb3d04d1.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1971E

Surgical Innovations Group PLC

16 October 2018

Surgical Innovations Group plc

(the "Company")

Director/PDMR Shareholding

The Company has been notified that Nigel Rogers, Executive Chairman, today:

(i)     acquired 750,000 ordinary shares of 1 penny each in the Company ("Shares") within his ISA, at a price of 2.95p per share; and

(ii)   sold 416,830 Shares at a price of 2.95p per share.

Following these transactions, the beneficial holding of Nigel Rogers in the Company is 6,610,000

Shares, representing approximately 0.84% of the issued share capital of the Company.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

For further information please contact:

Surgical Innovations Group plc

Nigel Rogers, Executive Chairman Melanie Ross, COO & CFO

WH Ireland Limited (NOMAD & Broker)

Tim Feather

Walbrook PR  (Financial PR & Investor Relations)

Paul McManus Lianne Cawthorne
www.sigroupplc.com
Tel: 0113 230 7597
Tel: 0113 394 6600
Tel: 020 7933 8780 or [email protected]
Mob: 07980 541893
Mob: 07584 391303
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Nigel Rogers
2 Reason for the notification
a) Position/status Executive Chairman, Surgical Innovations Group plc
b) Initial notification/ Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Surgical Innovations Group plc
b) LEI 2138004GHGUH3HUZE156
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p

GB0004016704
b) Nature of the transactions Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
2.95p 750,000
d) Aggregated information

-     Aggregated volume

-     Price
750,000

£22,125
e) Date of the transaction 16 October 2018
f) Place of the transaction London Stock Exchange, AIM
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Nigel Rogers
2 Reason for the notification
a) Position/status Executive Chairman, Surgical Innovations Group plc
b) Initial notification/ Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Surgical Innovations Group plc
b) LEI 2138004GHGUH3HUZE156
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p

GB0004016704
b) Nature of the transactions Sale of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
2.95p 416,830
d) Aggregated information

-     Aggregated volume

-     Price
416,830

£12,296
e) Date of the transaction 16 October 2018
f) Place of the transaction London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGCBDGCSBBGIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.